Asio Capital LLC grew its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 5.7% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 15,599 shares of the healthcare conglomerate's stock after purchasing an additional 848 shares during the quarter. UnitedHealth Group makes up 1.6% of Asio Capital LLC's portfolio, making the stock its 17th biggest position. Asio Capital LLC's holdings in UnitedHealth Group were worth $8,170,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also recently modified their holdings of UNH. Geode Capital Management LLC raised its stake in shares of UnitedHealth Group by 1.6% during the 4th quarter. Geode Capital Management LLC now owns 19,956,219 shares of the healthcare conglomerate's stock worth $10,068,869,000 after acquiring an additional 319,515 shares in the last quarter. Capital International Investors increased its position in shares of UnitedHealth Group by 6.2% during the fourth quarter. Capital International Investors now owns 15,616,007 shares of the healthcare conglomerate's stock worth $7,899,905,000 after purchasing an additional 906,365 shares in the last quarter. Norges Bank acquired a new stake in shares of UnitedHealth Group in the 4th quarter worth $6,375,744,000. Northern Trust Corp raised its stake in UnitedHealth Group by 12.5% in the fourth quarter. Northern Trust Corp now owns 9,503,671 shares of the healthcare conglomerate's stock valued at $4,807,527,000 after buying an additional 1,058,488 shares during the last quarter. Finally, Franklin Resources Inc. grew its stake in shares of UnitedHealth Group by 10.7% during the fourth quarter. Franklin Resources Inc. now owns 8,923,770 shares of the healthcare conglomerate's stock worth $4,514,178,000 after acquiring an additional 861,854 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors.
Wall Street Analyst Weigh In
UNH has been the topic of several research analyst reports. Erste Group Bank downgraded shares of UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, April 30th. JPMorgan Chase & Co. reduced their target price on UnitedHealth Group from $525.00 to $405.00 and set an "overweight" rating for the company in a research note on Thursday, May 15th. Raymond James lowered UnitedHealth Group from a "strong-buy" rating to a "market perform" rating in a report on Wednesday, May 14th. KeyCorp reduced their price target on shares of UnitedHealth Group from $450.00 to $400.00 and set an "overweight" rating for the company in a research report on Monday, June 2nd. Finally, Wolfe Research reduced their target price on shares of UnitedHealth Group from $501.00 to $390.00 and set an "outperform" rating for the company in a report on Tuesday, May 20th. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and sixteen have issued a buy rating to the company. Based on data from MarketBeat, UnitedHealth Group presently has a consensus rating of "Moderate Buy" and a consensus price target of $426.52.
Check Out Our Latest Stock Analysis on UNH
Insider Buying and Selling
In other news, Director Timothy Patrick Flynn purchased 1,533 shares of the stock in a transaction dated Wednesday, May 14th. The stock was acquired at an average cost of $320.80 per share, for a total transaction of $491,786.40. Following the completion of the transaction, the director now directly owns 6,033 shares in the company, valued at approximately $1,935,386.40. This represents a 34.07% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO Stephen J. Hemsley bought 86,700 shares of the company's stock in a transaction on Friday, May 16th. The stock was purchased at an average cost of $288.57 per share, with a total value of $25,019,019.00. Following the completion of the transaction, the chief executive officer now owns 679,493 shares in the company, valued at $196,081,295.01. This represents a 14.63% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last ninety days, insiders bought 109,408 shares of company stock worth $31,607,768. Insiders own 0.28% of the company's stock.
UnitedHealth Group Price Performance
Shares of UnitedHealth Group stock traded down $5.11 during mid-day trading on Friday, reaching $313.39. 13,729,200 shares of the stock traded hands, compared to its average volume of 7,201,840. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a fifty-two week low of $248.88 and a fifty-two week high of $630.73. The stock has a market capitalization of $284.28 billion, a PE ratio of 20.22, a PEG ratio of 1.37 and a beta of 0.45. The business has a 50-day moving average of $386.66 and a 200 day moving average of $473.26.
UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. During the same quarter last year, the company earned $6.91 earnings per share. On average, analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.
UnitedHealth Group Increases Dividend
The company also recently declared a quarterly dividend, which will be paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th will be given a dividend of $2.21 per share. This is a boost from UnitedHealth Group's previous quarterly dividend of $2.10. The ex-dividend date of this dividend is Monday, June 16th. This represents a $8.84 annualized dividend and a dividend yield of 2.82%. UnitedHealth Group's payout ratio is presently 37.02%.
About UnitedHealth Group
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
See Also
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
